Rash LD - Search Results

1

Pharmacology and biochemistry of spider venoms.

Rash LD, Hodgson WC. Rash LD, et al. Toxicon. 2002 Mar;40(3):225-54. doi: 10.1016/s0041-0101(01)00199-4. Toxicon. 2002. PMID: 11711120 Review.

2

Evidence that histamine is the principal pharmacological component of venom from an Australian wolf spider (Lycosa godeffroyi).

Rash LD, King RG, Hodgson WC. Rash LD, et al. Toxicon. 1998 Feb;36(2):367-75. doi: 10.1016/s0041-0101(97)00072-x. Toxicon. 1998. PMID: 9620584

3

Sex differences in the pharmacological activity of venom from the white-tailed spider (Lampona cylindrata).

Rash LD, King RG, Hodgson WC. Rash LD, et al. Toxicon. 2000 Aug;38(8):1111-27. doi: 10.1016/s0041-0101(99)00226-3. Toxicon. 2000. PMID: 10708802

4

Neurotoxic activity of venom from the Australian eastern mouse spider (Missulena bradleyi) involves modulation of sodium channel gating.

Rash LD, Birinyi-Strachan LC, Nicholson GM, Hodgson WC. Rash LD, et al. Br J Pharmacol. 2000 Aug;130(8):1817-24. doi: 10.1038/sj.bjp.0703494. Br J Pharmacol. 2000. PMID: 10952670 Free PMC article.

5

Tarantulas: eight-legged pharmacists and combinatorial chemists.

Escoubas P, Rash L. Escoubas P, et al. Toxicon. 2004 Apr;43(5):555-74. doi: 10.1016/j.toxicon.2004.02.007. Toxicon. 2004. PMID: 15066413 Review.

6

Defining the role of post-synaptic α-neurotoxins in paralysis due to snake envenoming in humans.

Silva A, Cristofori-Armstrong B, Rash LD, Hodgson WC, Isbister GK. Silva A, et al. Among authors: rash ld. Cell Mol Life Sci. 2018 Dec;75(23):4465-4478. doi: 10.1007/s00018-018-2893-x. Epub 2018 Aug 1. Cell Mol Life Sci. 2018. PMID: 30069700

7

D. russelii Venom Mediates Vasodilatation of Resistance Like Arteries via Activation of K_v and K_Ca Channels.

Kakumanu R, Kuruppu S, Rash LD, Isbister GK, Hodgson WC, Kemp-Harper BK. Kakumanu R, et al. Among authors: rash ld. Toxins (Basel). 2019 Apr 1;11(4):197. doi: 10.3390/toxins11040197. Toxins (Basel). 2019. PMID: 30939844 Free PMC article.

8

Chemical synthesis and folding of APETx2, a potent and selective inhibitor of acid sensing ion channel 3.

Jensen JE, Durek T, Alewood PF, Adams DJ, King GF, Rash LD. Jensen JE, et al. Among authors: rash ld. Toxicon. 2009 Jul;54(1):56-61. doi: 10.1016/j.toxicon.2009.03.014. Epub 2009 Mar 21. Toxicon. 2009. PMID: 19306891

9

Spider-venom peptides as therapeutics.

Saez NJ, Senff S, Jensen JE, Er SY, Herzig V, Rash LD, King GF. Saez NJ, et al. Among authors: rash ld. Toxins (Basel). 2010 Dec;2(12):2851-71. doi: 10.3390/toxins2122851. Epub 2010 Dec 20. Toxins (Basel). 2010. PMID: 22069579 Free PMC article. Review.

10

Potent neuroprotection after stroke afforded by a double-knot spider-venom peptide that inhibits acid-sensing ion channel 1a.

Chassagnon IR, McCarthy CA, Chin YK, Pineda SS, Keramidas A, Mobli M, Pham V, De Silva TM, Lynch JW, Widdop RE, Rash LD, King GF. Chassagnon IR, et al. Among authors: rash ld. Proc Natl Acad Sci U S A. 2017 Apr 4;114(14):3750-3755. doi: 10.1073/pnas.1614728114. Epub 2017 Mar 20. Proc Natl Acad Sci U S A. 2017. PMID: 28320941 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

56 results

Search Page